"Sufficient life expectancy": an amazing inclusion criterion in cancer phase II-III trials.
Penel
Nicolas
N
Clisant
Stéphanie
S
Lefebvre
Jean-Louis
JL
Adenis
Antoine
A
D017322:Clinical Trials, Phase II as Topic / Q000379:methods* / Q000592:standards; D017326:Clinical Trials, Phase III as Topic / Q000379:methods* / Q000592:standards; D006801:Humans; D008017:Life Expectancy; D009369:Neoplasms / Q000473:pathology / Q000628:therapy*; D018579:Patient Selection; D011788:Quality of Life; D016019:Survival Analysis